Trial Details
COMPLETEDBasic Information
| Clinical ID | c1618 |
|---|---|
| Identifier | NCT03329209 |
| Trial Title | A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participants |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative|Crohn Disease |
| Interventions | DRUG: Vedolizumab |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Beijing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2018-03-05 |
|---|---|
| Primary Completion Date | 2018-07-26 |
| Completion Date | 2018-09-05 |